Nucleus Research, an independent research firm providing ROI-focused technology research services to both vendors and consumers, has published its Q2 2021 Equity Snapshot for Workday.
The Equity Snapshot highlights Workday’s long-term growth potential based on the company’s broad portfolio of human capital management (HCM) software solutions and continued up-front investments in R&D, cloud infrastructure and marketing. The company also offers some of the most advanced people analytics offerings currently available on the market, and its strong financials and HR integration remains a competitive advantage.
While Workday recently experienced strong customer growth with its dual HCM and enterprise resource planning (ERP) offerings, the company faces increased pressure from competitors expanding further into the enterprise space. Slower spending from mid-market companies will also inhibit near-term growth.
“Workday’s expansive portfolio of products supporting multiple areas of business make the vendor a compelling choice for business leaders who are looking for efficiency and a cohesive end-user experience,” said Research Manager Trevor White. “This type of connected workflow can significantly improve organizational visibility for users – which is a strong value proposition for Workday.”
As part of Workday’s commitment to expanding its product portfolio to meet the evolving needs of users, the company plans to launch its new Workday Talent Marketplace in October.
Nucleus Research listed Workday as an “Expert” in its 2021 HCM Value Matrix.
To download the full Q2 2021 Equity Snapshot for Workday, click here.
About Nucleus Research
Nucleus Research is a global provider of investigative, case-based technology research and advisory services. The company’s ROI-focused research approach provides unique insight into the actual results technology solutions deliver, allowing organizations to cut through marketing hype to understand real operational value and select or renew the best technology solution for their environment. For more information, visit NucleusResearch.com.